Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply.
Through its US and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximise API yield.
Vetter is holding a free webinar on Wednesday 15th October 2014, 5 pm (CEST), 11 am (EDT).
Regulatory agencies are seeking and implementing new methods to thwart prescription drug counterfeiting. Join Vetter for a live webcast that discusses serialization as an effective anti-counterfeiting solution.
Daniela Guttmann, Product and Service Manager and Alexander Ulbrich, Project Manager Serzialization at Vetter, will be hosting this event, which will answer the following questions:
- What are the drivers of serialization and where it's going within the biopharmaceutical industry?
- What do you have to keep in mind to implement serialization?
- How can a CDMO be prepared for updates and changes in customer and government requirements during a project run?
- What are the latest requirements and developments in the market?
- How can the challenges of integration of equipment components with existing packaging lines be overcome?
For more information and to register click here!
INFORMATION
This is a FREE streaming audio webinar and to attend you do not require a phone line.
Contact
Sonja Dirlewanger, Corporate Marketing, Vetter Pharma International GmbH
Tel: +49-(0)751-3700-3706